In models of diabetes and obesity, where circulating glucose levels are elevated, we consistently observed feminization of liver STAT5b function (Fig 2A), and feminization was at least partially reversed by leptin or resveratrol treatment (Figs 1D and 2C). This evidence concerns the gene STAT5B and obesity disorder.